• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主要炎症生物标志物在心房颤动发病机制中的作用

The Role of Major Inflammatory Biomarkers in the Pathogenesis of Atrial Fibrillation.

作者信息

Rafaqat Saira, Afzal Shaheed, Khurshid Huma, Safdar Sanober, Rafaqat Sana, Rafaqat Simon

机构信息

Lahore College for Women University, Lahore, Pakistan.

Punjab Institute of Cardiology, Lahore, Pakistan.

出版信息

J Innov Card Rhythm Manag. 2022 Dec 15;13(12):5265-5277. doi: 10.19102/icrm.2022.13125. eCollection 2022 Dec.

DOI:10.19102/icrm.2022.13125
PMID:37293559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10246921/
Abstract

Many studies have reported a relationship between inflammation and atrial fibrillation (AF). According to the literature, inflammation is the key component in pathophysiological processes during the development of AF; the amplification of inflammatory pathways triggers AF, and, at the same time, AF increases the inflammatory state. The plasma levels of several inflammatory biomarkers are elevated in patients with AF; therefore, inflammation might contribute to both the maintenance and occurrence of AF and its thromboembolic complications. Numerous inflammatory markers have been linked to AF, including CD40 ligand, fibrinogen, matrix metalloproteinase (MMP)-9, monocyte chemoattractant protein-1, myeloperoxidase, plasminogen activator inhibitor-1, and serum amyloid A. There are many pathophysiological aspects of AF that are linked to these inflammatory biomarkers, including atrial structural remodeling and atrial dilatation, increased atrial myocyte expression, fluctuations in calcium cycling, cardiac remodeling promotion, increased cardiac myocyte proliferation and terminal differentiation, production of several MMPs, the pathogenesis of atherosclerosis and cardiomyocyte apoptosis, an increased degree of fibrosis in atrial myocardium, and the progression and development of atherogenesis and atherothrombosis. The present review article aims to provide an updated overview and focus on the basic role of different biomarkers of inflammation in the pathophysiological aspects of the pathogenesis of AF.

摘要

许多研究报告了炎症与心房颤动(AF)之间的关系。根据文献,炎症是AF发生发展过程中病理生理过程的关键组成部分;炎症途径的放大引发AF,同时AF会加重炎症状态。AF患者的几种炎症生物标志物的血浆水平升高;因此,炎症可能促成AF的维持和发生及其血栓栓塞并发症。许多炎症标志物都与AF有关,包括CD40配体、纤维蛋白原、基质金属蛋白酶(MMP)-9、单核细胞趋化蛋白-1、髓过氧化物酶、纤溶酶原激活物抑制剂-1和血清淀粉样蛋白A。AF的许多病理生理方面都与这些炎症生物标志物有关,包括心房结构重塑和心房扩张、心房肌细胞表达增加、钙循环波动、促进心脏重塑、心肌细胞增殖和终末分化增加、几种MMP的产生、动脉粥样硬化和心肌细胞凋亡的发病机制、心房心肌纤维化程度增加以及动脉粥样硬化和动脉粥样血栓形成的进展和发展。本综述文章旨在提供最新概述,并聚焦于不同炎症生物标志物在AF发病机制病理生理方面的基本作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51f6/10246921/f3ba84db6e12/icrm-13-5265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51f6/10246921/f3ba84db6e12/icrm-13-5265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51f6/10246921/f3ba84db6e12/icrm-13-5265-g001.jpg

相似文献

1
The Role of Major Inflammatory Biomarkers in the Pathogenesis of Atrial Fibrillation.主要炎症生物标志物在心房颤动发病机制中的作用
J Innov Card Rhythm Manag. 2022 Dec 15;13(12):5265-5277. doi: 10.19102/icrm.2022.13125. eCollection 2022 Dec.
2
Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly.心房颤动对老年人炎症和纤溶指标的影响。
Scand J Clin Lab Invest. 2013;73(4):326-33. doi: 10.3109/00365513.2013.780093. Epub 2013 Apr 16.
3
Inflammatory Biomarkers in Atrial Fibrillation.心房颤动中的炎症标志物。
Curr Med Chem. 2019;26(5):837-854. doi: 10.2174/0929867324666170727103357.
4
Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.二尖瓣疾病和心房颤动患者中的基质金属蛋白酶与心房重构
Cardiovasc Res. 2005 Sep 1;67(4):655-66. doi: 10.1016/j.cardiores.2005.04.016.
5
Role of inflammation in atrial fibrillation pathophysiology and management.炎症在心房颤动病理生理学及管理中的作用。
Circ J. 2015;79(3):495-502. doi: 10.1253/circj.CJ-15-0138. Epub 2015 Feb 16.
6
The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.纤溶酶原激活物抑制物-1 在阵发性和持续性心房颤动中的作用。
Cytokine. 2018 Mar;103:63-68. doi: 10.1016/j.cyto.2017.12.026. Epub 2018 Jan 8.
7
Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.基质金属蛋白酶-9在心房颤动期间对人类心房重构有促进作用。
J Am Coll Cardiol. 2004 Mar 3;43(5):818-25. doi: 10.1016/j.jacc.2003.08.060.
8
Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation.心房颤动患者血小板CD40/CD40配体的表达及其与炎症标志物和黏附分子的关系。
Exp Biol Med (Maywood). 2007 Apr;232(4):581-9.
9
Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.炎症和细胞外基质代谢生物标志物对房颤消融结局的影响:基质金属蛋白酶-2作为房颤复发预测因子的重要性。
J Cardiovasc Electrophysiol. 2011 Sep;22(9):987-93. doi: 10.1111/j.1540-8167.2011.02059.x. Epub 2011 Apr 13.
10
Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation.骨保护素/核因子-κB 受体激活剂(RANK)/RANK 配体轴在心房颤动发生和进展中的心房基因表达失调。
Circ J. 2011;75(12):2781-8. doi: 10.1253/circj.cj-11-0795. Epub 2011 Oct 15.

引用本文的文献

1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
Effects of Heated Tobacco Use on Blood Parameters and Cardiovascular Risk in Healthy Men.加热烟草使用对健康男性血液参数和心血管风险的影响。
Med Sci Monit. 2025 Jul 14;31:e948556. doi: 10.12659/MSM.948556.
3
Atrial FDG uptake and atrial fibrillation: A systematic review and meta-analysis.

本文引用的文献

1
Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation.炎症、氧化应激和纤维化标志物在心房颤动患者中的研究
Oxid Med Cell Longev. 2022 May 23;2022:4556671. doi: 10.1155/2022/4556671. eCollection 2022.
2
The systemic-immune-inflammation index predicts the recurrence of atrial fibrillation after cryomaze concomitant with mitral valve surgery.全身免疫炎症指数可预测冷冻迷宫联合二尖瓣手术后心房颤动的复发。
BMC Cardiovasc Disord. 2022 Feb 13;22(1):45. doi: 10.1186/s12872-022-02494-z.
3
Myeloperoxidase in the pericardial fluid improves the performance of prediction rules for postoperative atrial fibrillation.
心房氟脱氧葡萄糖摄取与心房颤动:一项系统评价和荟萃分析。
Heart Rhythm O2. 2025 Jan 10;6(4):417-423. doi: 10.1016/j.hroo.2025.01.002. eCollection 2025 Apr.
4
Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation.髓过氧化物酶和N端前心钠素作为再次消融患者房颤复发的预测指标。
Heart Rhythm O2. 2024 Sep 13;5(11):770-777. doi: 10.1016/j.hroo.2024.09.003. eCollection 2024 Nov.
5
and Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase.以及β-谷甾醇纳米颗粒作为针对髓过氧化物酶治疗异丙肾上腺素诱导的心肌梗死认知障碍的潜在疗法的研究。
Pharmaceuticals (Basel). 2024 Aug 21;17(8):1093. doi: 10.3390/ph17081093.
6
Exploring Diet-Based Treatments for Atrial Fibrillation: Patient Empowerment and Citizen Science as a Model for Quality-of-Life-Centered Solutions.探讨基于饮食的心房颤动治疗方法:以患者赋权和公民科学为模型的以生活质量为中心的解决方案。
Nutrients. 2024 Aug 13;16(16):2672. doi: 10.3390/nu16162672.
7
Fibrinaloid Microclots and Atrial Fibrillation.纤维蛋白样微血栓与心房颤动
Biomedicines. 2024 Apr 17;12(4):891. doi: 10.3390/biomedicines12040891.
8
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide.心房颤动伴循环脂多糖升高患者的纤维蛋白溶解功能受损。
J Thromb Thrombolysis. 2024 Jun;57(5):842-851. doi: 10.1007/s11239-024-02980-5. Epub 2024 Apr 21.
9
Outcome of Atrial Fibrillation Ablation in Cancer Patients: A Review.癌症患者心房颤动消融的结果:综述
Cureus. 2023 Oct 27;15(10):e47818. doi: 10.7759/cureus.47818. eCollection 2023 Oct.
心包液中的髓过氧化物酶提高了术后心房颤动预测规则的性能。
J Thorac Cardiovasc Surg. 2023 Mar;165(3):1064-1077.e8. doi: 10.1016/j.jtcvs.2021.06.027. Epub 2021 Jun 22.
4
Enhanced monocyte migratory activity in the pathogenesis of structural remodeling in atrial fibrillation.增强的单核细胞迁移活性在心房颤动的结构重塑发病机制中的作用。
PLoS One. 2020 Oct 13;15(10):e0240540. doi: 10.1371/journal.pone.0240540. eCollection 2020.
5
Evidence for Inflammation as a Driver of Atrial Fibrillation.炎症作为心房颤动驱动因素的证据。
Front Cardiovasc Med. 2020 Apr 29;7:62. doi: 10.3389/fcvm.2020.00062. eCollection 2020.
6
Myeloperoxidase in atrial fibrillation: association with progression, origin and influence of renin-angiotensin system antagonists.心房颤动中的髓过氧化物酶:与进展、起源的关系及肾素-血管紧张素系统拮抗剂的影响。
Clin Res Cardiol. 2020 Mar;109(3):324-330. doi: 10.1007/s00392-019-01512-z. Epub 2019 Jun 24.
7
Impact of inflammation-mediated myocardial fibrosis on the risk of recurrence after successful ablation of atrial fibrillation - the FIBRO-RISK study: Protocol for a non-randomized clinical trial.炎症介导的心肌纤维化对心房颤动成功消融术后复发风险的影响——FIBRO-RISK研究:一项非随机临床试验方案
Medicine (Baltimore). 2019 Mar;98(9):e14504. doi: 10.1097/MD.0000000000014504.
8
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.遗传决定的循环细胞因子水平与中风风险。
Circulation. 2019 Jan 8;139(2):256-268. doi: 10.1161/CIRCULATIONAHA.118.035905.
9
Role of inflammatory signaling in atrial fibrillation.炎症信号在心房颤动中的作用。
Int J Cardiol. 2019 Jul 15;287:195-200. doi: 10.1016/j.ijcard.2018.10.020. Epub 2018 Oct 4.
10
Inflammation and atrial fibrillation: A comprehensive review.炎症与心房颤动:综述
J Arrhythm. 2018 Jun 4;34(4):394-401. doi: 10.1002/joa3.12077. eCollection 2018 Aug.